Xilio Therapeutics (XLO) Treasury Shares (2020 - 2021)

Xilio Therapeutics has disclosed Treasury Shares across 2 years of filings, most recently posting $174.8 million for Q3 2021.

• In Q3 2021, Treasury Shares rose 340.0% year-over-year to $174.8 million; the TTM figure through Sep 2021 stood at $174.8 million (up 340.0% YoY), while the FY2020 annual figure was $66.8 million, changed N/A from the prior year.
• Treasury Shares came in at $174.8 million for Q3 2021 at Xilio Therapeutics, up from $79.4 million in the prior quarter.
• In the past five years, Treasury Shares ranged from a high of $174.8 million in Q3 2021 to a low of $39.7 million in Q3 2020.